|
|
|
|
LEADER |
01773nam a2200277 u 4500 |
001 |
EB001897038 |
003 |
EBX01000000000000001060043 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200523 r ||| eng |
020 |
|
|
|a 9781473125537
|
245 |
0 |
0 |
|a Surveillance report (exceptional review) 2017: Cancer of the upper aerodigestive tract
|h Elektronische Ressource
|b assessment and management in people aged 16 and over (2016) NICE guideline NG36
|
246 |
3 |
1 |
|a Cancer of the upper aerodigestive tract
|
260 |
|
|
|a [London]
|b National Institute for Health and Care Excellence
|c 20 July 2017, 2017
|
300 |
|
|
|a 1 PDF file (6 pages)
|
653 |
|
|
|a United Kingdom
|
653 |
|
|
|a Neoplasm Metastasis / therapy
|
653 |
|
|
|a Head and Neck Neoplasms / diagnostic imaging
|
653 |
|
|
|a Positron Emission Tomography Computed Tomography
|
710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Surveillance report
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK550714
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The PET-NECK study is a National Institute for Health Research (NIHR) funded trial that is relevant to NICE's guideline on upper aerodigestive cancer. The aim of this trial is to determine the efficacy and cost-effectiveness of PET-CT guided surveillance compared to planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. This trial was raised by stakeholders during consultation for the guideline, subsequently added to the NICE surveillance programme trial tracker and results considered in detail when they became available
|